In this issue:
Effect of time from diagnosis to treatment in AML
Inhibition of Bcl-xL deamidation in myelo-proliferative disorders
SGN-40 activity enhanced by lenalidomide in CLL
Dose-dense induction with S-HAM/peg- filgrastim in AML
Age and AML: real world data on decision to treat and outcomes
Multivariate analysis of febrile neutropenia in NHL
High-dose Ara-C + BEAM with autograft rescue in R-CHOP responsive MCL
Organochlorine exposure, immune gene variation and NHL risk
Adding rituximab to CHOP improves response in LPL
Overall survival in erythrodermic CTCL
Please login below to download this issue (PDF)